Neutral Portfolio (Copy)

Neutral Portfolio (Copy) - Page Text Content

FC: BIOTECHNOLOGY SOCIETY 2011-2012

1: About.... | What is the Biotechnology Society? Founded in 2006, the Biotech Society is an extension of the Professional Program in Biotechnology (PPib). The society provides a platform for students to network with professionals from the industry, seek advice from faculty and alumni and interact with fellow students sharing similar scientific intellect. | Who participates ? Current students, former students, alumni, faculty, industrial advisers, guest speakers are key partakers of the society. | What kind of events? Members of the Biotech Society have shown keen interests whether it meant interactive discussions with guest speakers or wavering away from the TAMU campus for industrial visits. Non-curricular social events like the Big Event, Replant Day, alumni BBQ, graduate farewell have been student's favorites.

6: Life Technologies | Life Technologies is a global life science leader. They offer products and services ranging from instruments to everyday lab essentials. ensuring quality and performance. IndustryWeek magazine, in 2011 named the Life Technologies Corporation plant in Austin, Texas, one of its Top Ten Plants in North America for 2011, making it the first biotechnology facility to win the prestigious award. The Austin facility produces more than 670 widely used products, including RNA Isolation kits, MessageAMP kits and RNA Stabilizing Reagents under the Ambion®, Applied Biosystems® and Invitrogen brand names.

7: Life Technologies - Austin | '' '' - AParna Krishnan | Chris Brunette - SO and So and also a part of the advisory council

8: Caliber Biotherapeutics College Station | Caliber Biotherapeutics is a fully integrated pharmaceutical company dedicated to delivering new, more effective vaccines and biotherapeutics for cancer, infectious diseases, and other human afflictions. By leveraging modular production technologies and multiple development systems (plants, cells, and microbes), we are pioneering new treatments with increased safety and effectiveness, while reducing both costs and development time.